At211Astatine 211

Astatine-211 is a radioisotope used in in targeted alpha therapy. It has a half-life of 7,2 hours. 211At is mainly used for treatment of cancer.

To produce Astatine 211,
we recommend this production route:

  • Recommended

    Cyclone:

    Cyclone® 30 XP

    Download the brochure

    211At is produced with a cyclotron using alpha beam at 30 MeV

    More about Cyclone® 30 XP

    Target:

    Nirta® Solid target 30 MeV

    209Bi (nat-Bismuth) is irradiated  in the solid target creating 209Bi(α,3n)211At nuclear reaction.

    IBA provides only the irradiation station equipment.

    Chemistry:

    Thermodistillation module

    Irradiated target is place in the module and 211At is extracted  via thermodistillation.

Scientific publications